Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,356.00
Bid: 12,390.00
Ask: 12,394.00
Change: 28.00 (0.23%)
Spread: 4.00 (0.032%)
Open: 12,364.00
High: 12,454.00
Low: 12,322.00
Prev. Close: 12,328.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-UK stocks recover on Brexit progress hopes after virus-led pullback

Tue, 22nd Dec 2020 10:10

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* Britain's fishing rights offer raises hopes for a deal

* UK economy recovers 16% in Q3, recession risks loom

* AstraZeneca down as asthma drug trial fails

* FTSE 100 up 0.6%, FTSE 250 adds 1.3%
(Updates to market close)

By Medha Singh

Dec 22 (Reuters) - UK stocks bounced on Tuesday as fresh
hopes of a trade deal with the European Union outweighed fears
over a mutated variant of the novel coronavirus that has shut
most of the island country.

The mid-cap FTSE 250, considered a barometer for
Brexit sentiment, added 1.3% as the EU chief negotiator said
both sides were inching towards an agreement on fishing though
the politically sensitive matter remains unresolved.

Banks and industrials and consumer discretionary were the
biggest boost to the domestically focused index.

The blue-chip FTSE 100 closed 0.6% after wiping off
more than half of its gains for December on Monday as UK imposed
tough restrictions and countries around the world shut their
borders to Britain due to worries about the new variant.

"The COVID crisis and Brexit uncertainty look set to hang
over equities for the rest of the calendar year and January
could be a difficult period unless there is progress in getting
the virus under control and clarity on when more people will get
vaccinated," said Russ Mould, investment director at AJ Bell.

Official data showed Britain's economic recovery from its
coronavirus crash was quicker than previously thought in the
third quarter, but new lockdowns are threatening to cause a
another recession.

Drugmaker AstraZeneca Plc slipped 1.5% after its
experimental asthma drug with Amgen Inc failed to meet
the main goal of reducing patients' dependence on steroids in a
late-stage trial.

Irish gas station operator Applegreen Plc rose
2.5% after agreeing to be acquired by a consortium led by B&J
Holdings and Blackstone Infrastructure Partners in a deal that
valued it at around $877.66 million.
(Reporting by Medha Singh and Shivani Kumaresan in Bengaluru;
Editing by Rashmi Aich, Sriraj Kalluvila and Richard Chang)

More News
1 Jun 2023 07:40

AstraZeneca gets another US approval for Lynparza

(Sharecast News) - AstraZeneca has received approval in the United States for the drug combination of 'Lynparza', or olaparib, with abiraterone and prednisone or prednisolone for the treatment of adult patients suffering from metastatic castration-resistant prostate cancer (mCRPC) with deleterious or suspected deleterious BRCA mutations, it announced on Thursday.

Read more
31 May 2023 23:35

US FDA approves Pfizer's RSV vaccine

May 31 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved Pfizer Inc's respiratory syncytial virus (RSV) vaccine for older adults, making it the second shot against the common respiratory disease that can be fatal for seniors.

Read more
26 May 2023 16:57

Mining stocks lift FTSE 100 higher, though UK equities log weekly declines

Kin & Carta cuts FY sales outlook, shares tumble

*

Read more
26 May 2023 14:34

TOP NEWS: AstraZeneca's Ultomiris wins another approval in Japan

(Alliance News) - AstraZeneca PLC on Friday announced that its antibody complement inhibitor drug Ultomiris received another approval in Japan.

Read more
26 May 2023 08:14

AstraZeneca's Imfinzi plus Lynparza effective for endometrial cancer

(Alliance News) - AstraZeneca PLC on Friday said that its most recent trial testing Imfinzi showed that the therapy significantly improved progression-free survival in advanced endometrial cancer when added to chemotherapy.

Read more
26 May 2023 07:57

LONDON BRIEFING: UK retail sales up; Hunt "comfortable" with recession

(Alliance News) - Stocks in London are expected to kick off the final trading day of a fraught week with a minor gain, though US debt ceiling uncertainty continues to temper sentiment.

Read more
26 May 2023 07:02

AstraZeneca's Imfinzi shows positive results for endometrial cancer patients

(Sharecast News) - AstraZeneca said results from a Phase III trial showed its Imfinzi treatment in combination with chemotherapy showed a significant improvement in patients with endometrial cancer.

Read more
22 May 2023 08:42

IN BRIEF: AstraZeneca hires LSEG CFO Anna Manz as non-exec director

AstraZeneca PLC - Cambridge, England-based pharmaceutical maker - Hires Chief Financial Officer Anna Manz of London Stock Exchange Group PLC as a non-executive director from September 1. Manz joined the price data, trading and clearing systems operator in November 2020 as CFO. She was CFO of speciality chemicals Johnson Matthey PLC from 2016 to 2020. Prior to that, Manz spent 17 years at London-based brewer and distiller Diageo PLC in a number of senior finance roles, Astra noted.

Read more
17 May 2023 09:53

AstraZeneca's Tagrisso plus chemotherapy effective against lung cancer

(Alliance News) - AstraZeneca PLC on Wednesday said its Tagrisso, used together with chemotherapy, showed improvement in progression-free survival for patients with lung cancer.

Read more
17 May 2023 07:29

AstraZeneca reports positive results in latest lung cancer trials

(Sharecast News) - AstraZeneca said on Wednesday that its 'FLAURA2' phase three trial had yielded positive high-level results, demonstrating the potential of 'Tagrisso', or osimertinib, combined with chemotherapy in lung cancer patients.

Read more
16 May 2023 14:12

AstraZeneca to leave leading U.S. drug lobby group

LONDON, May 16 (Reuters) - AstraZeneca has decided to leave the main U.S. drug lobby group, the Pharmaceutical Research and Manufacturers of America (PhRMA), and pursue other ways of engaging in advocacy at the state and federal level, the company said.

Read more
16 May 2023 12:34

AstraZeneca to leave leading U.S. drug lobby group

LONDON, May 16 (Reuters) - AstraZeneca has decided to leave the main U.S. drug lobby group, the Pharmaceutical Research and Manufacturers of America (PhRMA), and pursue other ways of engaging in advocacy at the state and federal level, the company said.

Read more
11 May 2023 17:43

UK's FTSE index ends flat; little reaction to BoE rate decision

BoE lifts benchmark rate to 4.5% as expected

*

Read more
10 May 2023 17:14

FTSE 100 slips ahead of BoE decision, ASOS tumbles on weak sales

ASOS records worst day in over 10 months

*

Read more
10 May 2023 08:50

AstraZeneca's Ultomiris approved in EU for autoimmune disease NMOSD

(Alliance News) - AstraZeneca PLC on Wednesday said the European Commission approved its drug Ultomiris in the EU for adults with autoimmune disease neuromyelitis optica spectrum disorder, known as NMOSD.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.